Fig. 1.
Effects of transmembrane activator and calcium modulator and cyclophilin ligand interactor-immunoglobulin (TACI-Ig) on arthritis global assessment. TACI-Ig (6·3 mg/kg) diminished significantly arthritis global assessment from days 30 to 34 (P < 0·05). Data are expressed as mean ± standard deviation from 10 animals for each group. #P < 0·05 versus model group; ##P < 0·01 versus model group.